In vivo Western blot and qPCR results further demonstrated that FSTL1 expression and the pNF-κB/NF-κB ratio were elevated in the BLM group, suggesting that the FSTL1/NF-κB signaling pathway contributes to the progression of pulmonary fibrosis. This evidence concerns the gene NFKB1 and Bloom syndrome.